ADAURA Archives - Medical Conferences

Consistent efficacy of osimertinib in Chinese and global population

Presented By

Dr Jie Wang, Beijing Cancer Hospital, China

Trial

Phase 3, ADAURA

Conference

ELCC 2022

Type

Peer-reviewed article

25 May 2022 12:43

Phase III ADAURA Trial: CNS Recurrences slashed for NSCLC

Presented By

Prof. Roy Herbst, Yale Cancer Center, USA

Trial

Phase 3, ADAURA

Journal

Physician's Weekly

Conference

ESMO Virtual Congress 2020

18 April 2021 14:59

Adjuvant osimertinib in NSCLC reduces risk of CNS recurrence

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:05

Adjuvant osimertinib in NSCLC: practice changing ADAURA trial

Presented By

Prof. Roy S. Herbst, Yale Cancer Center, USA

Trial

Phase 3, ADAURA

Conference

ASCO 2020

8 September 2020 13:39

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com